Literature DB >> 19778810

[Expression of Aurora-B in non-small cell lung cancer and its clinical significance].

Wen-rui Wang1, Sheng-sheng Yang, Jing-xiang Lin, Zhi-yong Zeng, Dao-ming Liu, Hong-tao Liu.   

Abstract

OBJECTIVE: To study the expression of Aurora-B in non-small cell lung cancer (NSCLC) tissues and NSCLC cell lines.
METHOD: Aurora-B expression was examined using immunohistochemical SP method in 91 stage I and 69 stage II-III NSCLC tissues and 40 adjacent tissues. The mRNA and protein expressions of Aurora-B in NSCLC cell lines (A549, H460 and H1299) were examined by RT-PCR and Western blotting, respectively.
RESULTS: The protein expression of Aurora-B was detected in 77.7% (94/121) of the tumor tissues and 9.8% (4/41) of the adjacent tissues, showing a significant difference between them (P<0.01). The positivity rate of Aurora-B protein was not related with the gender and age of NSCLC patients, but with lymph node metastasis, differentiation and histological type of NSCLC (P<0.05). Aurora-B was expressed in all the NSCLC cell lines (A549, H460 and H1299) at both mRNA and protein levels. A549 cells showed the highest expression of Aurora-B.
CONCLUSION: Aurora-B protein is highly expressed in NSCLC tissues and cell lines, and may play a crucial role in the invasion, metastasis and development of NSCLC. The mRNA and protein expression levels of Aurora-B differ significantly between different NSCLC cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778810

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  4 in total

1.  Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells.

Authors:  Jing Jing Yu; Long Dian Zhou; Tian Tian Zhao; Wei Bai; Jing Zhou; Wei Zhang
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

2.  RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  Long Dian Zhou; Xu Xiong; Xin Hua Long; Zhi Li Liu; Shan Hu Huang; Wei Zhang
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

Review 3.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

4.  Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion.

Authors:  Xiao Ping Zhu; Zhi Li Liu; Ai Fen Peng; Yun Fei Zhou; Xin Hua Long; Qing Feng Luo; Shan Hu Huang; Yong Shu
Journal:  Exp Ther Med       Date:  2014-01-20       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.